T1	Participants 81 120	patients with resectable gastric cancer
T2	Participants 329 382	386 Japanese patients with resectable gastric cancer.
T3	Participants 491 536	264 patients with curatively resected cancer,
T4	Participants 760 772	264 patients
T5	Participants 1044 1078	curatively resected gastric cancer
